NCT06788756 2026-04-13L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AMLMoleculin Biotech, Inc.Phase 2/3 Recruiting312 enrolled